Clinical Trial Update: Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing antazoline to propafenone for pharmacological cardioversion in atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Antazoline (antazoline)
• Propafenone (propafenone)

Snippet

Sponsor: Centre of Postgraduate Medical Education | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN